Form 4 for EXPO EXPONENT INC
Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-17 · accession 0000851520-25-000078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-18 | 2025-11-17 | EXPO | Corrigan Catherine | Pres, CEO, Dir | M - OptEx | $26.96 | +5,605 | 86.7K | +7% | +$151.1K |
| DM | 2025-11-18 | 2025-11-17 | EXPO | Corrigan Catherine | Pres, CEO, Dir | S - Sale+OE | $70.39 | -4,900 | 83.4K | -6% | -$344.9K |
| DM | 2025-11-18 | 2025-11-17 | EXPO | Corrigan Catherine | Pres, CEO, Dir | M - OptEx | — | -5,605 | 19.4K | -22% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-17 | M | A | 2,380 | $29.05 | 85,809 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-17 | M | A | 3,225 | $25.41 | 86,654 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-17 | S | D | 1,675 | $70.74 | 84,134 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-17 | S | D | 3,225 | $70.21 | 83,429 | D | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-11-17 | M | D | 2,380 | — | 19,038 | D | $29.05 · — to 2027-02-16 | 2,380 Common Stock | (F3) Not applicable. (F2) The stock option becomes exercisable in four equal annual installments. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-11-17 | M | D | 3,225 | — | 19,353 | D | $25.41 · — to 2026-07-29 | 3,225 Common Stock | (F3) Not applicable. (F2) The stock option becomes exercisable in four equal annual installments. |